Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutation screen and association study of EZH2 as a susceptibility gene for aggressive prostate cancer.

The Prostate - 1 Nov 2005

Bachmann Natascha, Hoegel Josef, Haeusler Juergen, Kuefer Rainer, Herkommer Kathleen, Paiss Thomas, Vogel Walther, Maier Christiane

Abstract excerpt

BACKGROUND: Several linkage studies have provided evidence for a prostate cancer aggressiveness gene on chromosome 7q. This report details the results of the first mutation screen and association study of EZH2 (located at 7q35) as a potential candidate gene for the development of aggressive prost...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA-Binding Proteins
Share to DNA, Neoplasm
Share to Enhancer of Zeste Homolog 2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Linkage Disequilibrium

Share to Polycomb Repressive Complex 2

Share to Prostatic Neoplasms

Share to Proteins

Share to Transcription Factors

Source

Identifiers

PMID: 16015586
DOI: 10.1002/pros.20296

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-16015586-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutation screen and association study of EZH2 as a susceptibility gene for aggressive prostate cancer.PMID 16015586Read ↗

ANO7 is associated with aggressive prostate cancer.Semantic proximity Read ↗

Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies.Semantic proximity Read ↗

Linkage of aggressive prostate cancer to chromosome 7q31-33 in German prostate cancer families.Semantic proximity Read ↗

A rare variant in EZH2 is associated with prostate cancer risk.Semantic proximity Read ↗

Association of a CAV-1 haplotype to familial aggressive prostate cancer.Semantic proximity Read ↗

Two susceptibility loci identified for prostate cancer aggressiveness.Semantic proximity Read ↗

Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parametersSemantic proximity Read ↗

Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma.Semantic proximity Read ↗

Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy.Semantic proximity Read ↗

Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.Semantic proximity Read ↗

The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late‐stage prostate cancerSemantic proximity Read ↗

E-cadherin promoter polymorphisms are not associated with the aggressiveness of prostate cancer in Caucasian patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.